1. |
New therapies for mature T-cell leukaemia? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
2. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
3. |
Meglitinide analogues show promise in type 2 diabetes |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
4. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
5. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
6. |
Eptifibatide'highly cost-effective'for coronary stenting |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
7. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
8. |
Fulvestrant looks on track to fulfil expectations in advanced breast cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 9-10
Sushma Soni,
Preview
|
|
摘要:
Fulvestrant, the first in a new class of antiestrogens, is at least as effective as anastrozole in the second-line treatment of advanced breast cancer, according to a new analysis of data presented at ECCO 11 - the European Cancer Conference [Lisbon, Portugal; October 2001]. Fulvestrant [ICI 182,780; 'Faslodex'] is a novel 'pure' antiestrogen, devoid of estrogen-like activity. This characteristic sets fulvestrant apart from tamoxifen, the current gold standard endocrine therapy for breast cancer. In a symposium at the meeting, Professor Kathleen Pritchard from the Toronto-Sunnybrook Regional Cancer Centre, Ontario, Canada, spoke about recent advances and future directions in hormonal therapy for breast cancer, and commented that'the drug Faslodex has been of a lot of interest to many of us for a long time, because ... it represents the one available drug we have from a novel drug class'.1
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
9. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
10. |
Oral triptans: equally effective overall |
|
Inpharma Weekly,
Volume &NA;,
Issue 1315,
2001,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|